Clinical Outcomes in Routine Evaluation 10 (CORE-10)

1. Abstract

The Clinical Outcomes in Routine Evaluation 10 (CORE-10) is a brief, ten-item self-report questionnaire designed to assess global psychological distress and track therapeutic change within routine mental health services, primary care, and counseling settings. Derived directly from the comprehensive 34-item Clinical Outcomes in Routine Evaluation-Outcome Measure (CORE-OM), the CORE-10 was constructed to provide a low-burden, psychometrically robust instrument capable of frequent, session-by-session administration. The instrument evaluates core facets of subjective psychological state across anxiety, depression, physical manifestations of stress, interpersonal coping, trauma-related re-experiencing, and explicit suicidal ideation. Items are rated on a 5-point Likert scale ranging from 0 (“Not at all”) to 4 (“Most or all of the time”) based on the respondent’s experiences over the preceding seven days. Psychometric investigations reveal outstanding properties, including high internal consistency (Cronbach’s alpha of approximately .90), strong convergent validity with extensive clinical measures such as the Beck Depression Inventory (BDI-II) and the Patient Health Questionnaire-9 (PHQ-9), and high sensitivity to therapeutic progress. Exploratory and confirmatory factor analytic studies generally substantiate a robust, dominant general factor reflecting general psychological distress, validating the utilization of an aggregated total score (ranging from 0 to 40). A standard clinical cutoff score of 11 or higher differentiates non-clinical populations from individuals presenting with clinically significant psychological morbidity. By balancing diagnostic sensitivity, structural brevity, and clinical utility—including a critical embedded risk item—the CORE-10 serves as an indispensable tool for evidence-based psychotherapeutic practice, service evaluation, and psychiatric monitoring globally.

2. Keywords

CORE-10, Clinical Outcomes in Routine Evaluation, psychological distress, measurement-based care, outcome monitoring, psychotherapy outcomes, routine clinical evaluation, depression screening, anxiety assessment, suicide risk screening, psychometrics, counseling evaluation.

3. Authors

The CORE-10 was developed through the collaborative efforts of the CORE System Group, a team of leading clinical psychologists, psychometricians, and health service researchers in the United Kingdom dedicated to standardizing psychological therapy auditing and outcome measurement:

• Michael Barkham, Ph.D. — Professor of Clinical Psychology, Centre for Psychological Services Research, Department of Psychology, University of Sheffield, Sheffield, United Kingdom.
• Brenda M. Bewick, Ph.D. — Associate Professor in Psychological Health and Wellbeing, School of Medicine, University of Leeds, Leeds, United Kingdom.
• Tony Mullin — Research Fellow and Psychotherapist, Psychological Therapies Research Centre, University of Leeds, Leeds, United Kingdom.
• Simon Gilbody, D.Phil., FRCPsych — Professor of Psychological Medicine and Health Services Research, Mental Health and Addictions Research Group (MHARG), Hull York Medical School and Department of Health Sciences, University of York, York, United Kingdom.
• Janice Connell, Ph.D. — Senior Research Fellow, School of Health and Related Research (ScHARR), University of Sheffield, Sheffield, United Kingdom.
• Jane Cahill, Ph.D. — Clinical Research Psychologist, Psychological Therapies Research Centre, University of Leeds, Leeds, United Kingdom.
• Chris Evans, MD, FRCPsych — Visiting Professor of Psychometrics and Psychotherapy, University of Roehampton, and Consultant Psychiatrist in Psychotherapy, United Kingdom.

4. Purpose

The primary clinical and research purpose of the Clinical Outcomes in Routine Evaluation 10 (CORE-10) is to provide a brief, psychometrically sound, open-access metric of subjective psychological distress suitable for universal application across mental health systems. Modern psychological therapy services, particularly public health frameworks such as the UK National Health Service (NHS) Talking Therapies initiative (formerly known as Improving Access to Psychological Therapies or IAPT), operate under stringent mandates to demonstrate clinical efficacy, cost-effectiveness, and real-time risk surveillance. While comprehensive multi-domain batteries such as the 34-item CORE-OM offer exceptional diagnostic granularity, their length frequently imposes an administrative burden that impedes compliant, session-by-session outcome tracking. The CORE-10 was explicitly engineered to address this clinical barrier by distilling the core dimensional spectrum of psychological distress into a brief, ten-item format.

In routine clinical practice, the CORE-10 functions across three primary domains: screening, routine progress monitoring, and aggregate service evaluation. At initial intake or primary care consultation, the instrument serves as a rapid screening measure capable of distinguishing between transient life stress and clinically actionable psychological morbidity. Because it samples affective, cognitive, somatic, and interpersonal domains without relying heavily on medicalized psychiatric nomenclature, it is highly acceptable to patients from diverse sociocultural backgrounds. Clinicians utilize baseline scores to gauge severity, establish baseline severity benchmarks, and formulate targeted treatment interventions.

Throughout the psychotherapeutic process, the instrument is administered repeatedly to facilitate measurement-based care. Session-by-session tracking permits clinicians to identify sudden therapeutic gains, plateauing of recovery trajectories, or insidious clinical deterioration. This real-time feedback loop allows for timely modifications of clinical formulation, therapeutic alliance exploration, or intervention escalation. Crucially, Item 6 specifically screens for plans of self-harm or suicide (“I made plans to end my life”), functioning as an immediate red-flag clinical indicator that mandates real-time clinical assessment, irrespective of whether the composite score reaches diagnostic thresholds.

In research contexts, the CORE-10 provides a unified metric for naturalistic outcome studies, randomized controlled trials (RCTs), and benchmarking audits across heterogeneous diagnostic presentations. Its shared metric with the CORE-OM allows cross-study comparisons, enabling longitudinal tracking of community counseling initiatives, university psychological services, and secondary psychiatric outpatient services.

5. Psychological Construct

The CORE-10 operationalizes the overarching psychological construct of general psychological distress (often conceptualized psychometrically as subjective dysphoria or demoralization). Rather than isolating a single narrow diagnostic pathology such as unipolar major depressive disorder or specific phobia, the instrument captures the transdiagnostic, common-factor vulnerability that underpins the vast majority of non-psychotic clinical presentations. Grounded in the multi-domain architecture of the broader CORE assessment system, the 10 items encapsulate six interrelated psychological dimensions:

Anxiety and Physiological Tension

The physiological, autonomic, and cognitive manifestations of generalized anxiety and acute panic constitute a central component of psychological distress. The CORE-10 evaluates these states through items assessing pervasive tension and nervous arousal (Item 1: “I have felt tense, anxious or nervous”) as well as severe autonomic surge or panic-related terror (Item 5: “I have felt panic or terror”). This captures both baseline neurobiological overarousal and acute somatic distress characteristic of panic and generalized anxiety states.

Depression, Despair, and Demoralization

Depressive symptomatology is evaluated through core cognitive, affective, and motivational features. The scale targets profound existential defeat and hopelessness (Item 8: “I have felt despairing or hopeless”), subjective affective unhappiness (Item 9: “I have felt unhappy”), and severe motivational or social exhaustion (Item 4: “Talking to people has felt too much for me”). These items align directly with key cognitive models of depression, capturing the psychological triad of negative self-evaluation, pervasive dysphoria, and psychomotor/social withdrawal.

Physical and Somatosensory Disruption

Psychological distress routinely compromises physical homeostasis. Sleep architecture is notoriously sensitive to neuroendocrine disruptions associated with distress. Item 7 (“I have had difficulty getting to sleep or staying asleep”) measures initial and middle insomnia, providing a direct physiological marker of affective disturbance, rumination, and somatic hyperarousal.

Intrusive and Traumatic Cognition

Expanding beyond traditional mood-anxiety frameworks, the CORE-10 integrates trauma-spectrum symptomatology. Item 10 (“Unwanted images or memories have been distressing me”) targets the phenomenon of intrusive recall, flashback phenomena, and unbidden traumatic cognitions. This recognizes trauma re-experiencing as a major contributor to global psychological impairment.

Positive Psychological Functioning and Coping Resources

Distress is not solely the presence of negative symptoms, but also the depletion of psychological resilience, self-efficacy, and perceived social support. Uniquely, the CORE-10 balances negative symptom items with two positively worded resilience indicators: social connectedness (Item 2: “I have felt I have someone to turn to for support when needed”) and perceived coping competence (Item 3: “I have felt able to cope when things go wrong”). Reverse-scored during quantitative analysis, these items gauge the erosion of protective internal and external resources.

Explicit Suicidal Risk

Recognizing the paramount clinical necessity of patient safety surveillance, the construct encompasses active self-harm ideation. Item 6 (“I made plans to end my life”) assesses active cognitive planning for suicide, capturing acute psychiatric risk and demoralization at their most severe clinical presentation.

6. Theoretical Framework

The structural and conceptual formulation of the CORE-10 is rooted in several influential theoretical paradigms within clinical psychology, psychometrics, and health services research:

Transdiagnostic Models and the “p Factor” of Psychopathology

Historically, psychological assessment relied heavily on categorical nosology, as exemplified by the American Psychiatric Association’s DSM and the World Health Organization’s ICD. However, contemporary empirical psychopathology (such as the Hierarchical Taxonomy of Psychopathology, or HiTOP) highlights the extensive comorbidity between emotional disorders, demonstrating that anxiety and depressive syndromes share a major underlying general psychopathology dimension—termed the general factor or p factor (Caspi et al., 2014). The CORE-10 is theoretically organized around this transdiagnostic common factor, postulating that a unified dimension of demoralization and psychological distress drives the vast majority of distress presentations seen in primary care and outpatient psychological therapies.

The Dose-Effect and Phase Models of Psychotherapy Recovery

The scale’s operationalization relies on Howard and colleagues’ (1993) Phase Model of Psychotherapy Outcome. This model posits that therapeutic recovery occurs across three sequential phases: (1) Remoralization (re-establishing hope and subjective well-being), (2) Remediation (reduction of specific psychiatric symptoms), and (3) Rehabilitation (unlearning unhelpful behaviors and establishing adaptive life functioning). By incorporating items spanning subjective well-being (Items 2 and 3), clinical symptoms (Items 1, 5, 7, 8, 9, 10), social functioning (Item 4), and acute risk (Item 6), the CORE-10 provides a sensitive barometer across all three phases of therapeutic recovery, capturing early remoralization as well as subsequent symptom alleviation.

The Generic Paradigm in Psychological Therapy Auditing

The CORE system emerged out of an initiative led by Barkham, Margison, Evans, and colleagues during the late 1990s to formulate a “pan-theoretical” assessment paradigm. Discontented with the fragmentation produced by modality-specific instruments (e.g., psychodynamic versus cognitive-behavioral assessment paradigms), the CORE System Group engineered an operational framework that evaluates outcome dimensions universally recognized by all psychological therapy modalities. This generic approach assumes that regardless of the theoretical mechanism—whether cognitive restructuring, affective processing, or relational dynamic interpretation—successful psychological therapy produces measurable reductions in distress, enhancements in perceived coping, and restoration of subjective well-being.

7. Validity

Extensive psychometric investigations have established strong validity parameters for the CORE-10 across primary care, secondary psychiatric services, university counseling centers, and non-clinical population cohorts.

Construct and Convergent Validity

Construct validity has been demonstrated through strong, statistically significant correlations with gold-standard dimensional instruments measuring anxiety, depression, and general psychopathology. In the seminal validation study by Barkham et al. (2013), the CORE-10 correlated exceptionally highly with its parent measure, the 34-item CORE-OM (r = .92 to .94 across clinical and non-clinical samples), demonstrating that the 10-item subset preserves the diagnostic and assessment fidelity of the full instrument. Furthermore, convergent validity analyses demonstrate robust correlations with established psychiatric scales:

• Beck Depression Inventory-II (BDI-II): Correlations typically range from r = .75 to .83, confirming strong alignment with cognitive-affective depressive symptomatology.
• Patient Health Questionnaire-9 (PHQ-9): Correlations range between r = .73 and .81 in primary care psychological therapy clinics.
• Generalized Anxiety Disorder 7-item scale (GAD-7): Significant positive correlations typically observed between r = .71 and .79.
• Clinical Outcomes in Routine Evaluation Short Form A and B (CORE-SF): Correlations systematically exceed r = .90.

Discriminant and Known-Groups Validity

The CORE-10 demonstrates pronounced known-groups validity, successfully differentiating between individuals within non-clinical general population samples and those actively seeking or receiving psychological care. In normative validation data reported by Barkham et al. (2013) and the CORE-10 Manual (2007):

• General Population Sample (n = 535): Mean score = 4.70 (SD = 4.80).
• Primary Care Counseling Clinical Sample (n = 1,835): Mean score = 19.70 (SD = 7.70).

This difference yielded a very large effect size (Cohen’s d = 2.34), confirming that the scale differentiates clinical distress from general population baseline states with exceptional clarity.

Diagnostic Accuracy and Receiver Operating Characteristic (ROC) Analyses

Receiver Operating Characteristic (ROC) curve analyses conducted by Barkham et al. (2013) evaluated the capacity of the CORE-10 to detect clinically significant psychopathology using established clinical caseness benchmarks. The Area Under the Curve (AUC) reached .92 (95% CI [.90, .94]), indicating excellent diagnostic discrimination. At the recommended clinical cutoff score of 11, the instrument achieved a sensitivity of 0.92 and a specificity of 0.72. For identifying probable moderate-to-severe major depressive disorder (using a threshold score of 13), the instrument maintained a sensitivity of 0.88 and a specificity of 0.76.

8. Reliability

The CORE-10 exhibits excellent reliability metrics across diverse clinical and non-clinical cohorts, confirming measurement stability, high internal consistency, and minimal measurement error.

Internal Consistency

Internal consistency estimates have been examined extensively across multiple clinical populations. In the initial validation study involving primary care counseling clients (n = 1,835), Barkham et al. (2013) reported a Cronbach’s alpha of .90. Subsequent international studies and adaptations have replicated these strong internal consistency metrics:

• General UK community adult samples: Cronbach’s α = .82 to .86.
• Primary care psychological therapies (IAPT / Talking Therapies): Cronbach’s α = .89 to .91.
• University and higher education student counseling services: Cronbach’s α = .87 to .90.
• Cross-cultural validation cohorts (e.g., European and Latin American translations): Cronbach’s α consistently exceeds the .80 benchmark, typically hovering around .85 to .88.

Omega hierarchical (ω_h) and categorical omega coefficients further confirm that the scale items tap a unified general dimension of distress with high internal reliability.

Test-Retest Reliability and Stability

Because the CORE-10 measures state psychological distress rather than immutable personality traits, scores are expected to fluctuate in response to therapeutic interventions and external life events. Nonetheless, when evaluated over short intervals in stable waitlist control or non-intervention community cohorts, the instrument exhibits strong temporal stability. Test-retest reliability evaluations over a 1-to-2-week period show Pearson correlation coefficients ranging from r = .75 to .85, demonstrating that baseline distress measurements remain stable in the absence of clinical intervention.

Standard Error of Measurement and Reliable Change Index (RCI)

Applying the classical test theory formula for the Standard Error of Measurement (SEM = SD × √(1 − α)), the SEM for the CORE-10 is approximately 2.4 points. Incorporating Jacobson and Truax’s (1991) methodology for clinical significance, the Reliable Change Index (RCI) requires a change of 6 points between assessment intervals to confirm that observed improvement or deterioration exceeds the threshold of measurement error at the 95% confidence level.

9. Factor Analysis

Extensive psychometric investigations utilizing exploratory factor analysis (EFA) and confirmatory factor analysis (CFA) have evaluated the latent structure of the CORE-10.

Exploratory Factor Analyses (EFA)

Initial EFAs conducted on clinical and non-clinical cohorts consistently yield an unrotated first factor that accounts for a substantial proportion of the total item variance (typically 45% to 55%). Eigenvalue decomposition routinely demonstrates a steep scree plot drop-off, with the first eigenvalue substantially exceeding the second (e.g., λ₁ ≈ 4.8 vs. λ₂ ≈ 0.95), fulfilling Kaiser’s criterion and parallel analysis thresholds for unidimensionality. Factor loadings across the 10 items on this dominant first factor are uniformly moderate to high:

• Item 1 (Tense, anxious or nervous): .72 – .78
• Item 2 (Someone to turn to for support – reversed): .45 – .55
• Item 3 (Able to cope when things go wrong – reversed): .58 – .68
• Item 4 (Talking to people too much): .64 – .74
• Item 5 (Panic or terror): .66 – .73
• Item 6 (Plans to end my life): .52 – .62
• Item 7 (Difficulty sleeping): .55 – .65
• Item 8 (Despairing or hopeless): .80 – .86
• Item 9 (Unhappy): .81 – .87
• Item 10 (Unwanted images/memories): .58 – .67

Confirmatory Factor Analyses (CFA)

CFA studies have modeled multiple competitive structural configurations: a strict unidimensional model, a correlated two-factor model (separating the 8 negatively worded items from the 2 positively worded items), and a bifactor model featuring a broad general distress factor alongside an orthogonal method factor for reversed items.

While a strict, unadjusted one-factor CFA model often yields marginal goodness-of-fit indices due to method effects associated with reverse-worded items (Item 2 and Item 3), modeling correlated error terms between Items 2 and 3 or applying a bifactor configuration yields exceptional model fit metrics across both clinical and community populations:

• Comparative Fit Index (CFI) ≥ .96
• Tucker-Lewis Index (TLI) ≥ .95
• Root Mean Square Error of Approximation (RMSEA) ≤ .055 (90% CI [.042, .068])
• Standardized Root Mean Square Residual (SRMR) ≤ .038

These findings substantiate that the CORE-10 items primarily reflect a robust, singular dimension of general psychological distress, validating the summation of all items into an aggregate total score.

10. Instrument / Measurement Tool

• Instrument Name: Clinical Outcomes in Routine Evaluation 10 (CORE-10).
• Parent Measure: Clinical Outcomes in Routine Evaluation-Outcome Measure (CORE-OM; 34 items).
• Target Population: Adults (aged 18 and older) in primary care, psychological therapy services, university counseling settings, and outpatient psychiatric clinics. (A specialized adolescent version, the CORE-YP, exists for younger cohorts).
• Administration Format: Paper-and-pencil questionnaire, web-based digital interface, or clinician-assisted interview.
• Administration Time: Approximately 2 to 3 minutes.
• Number of Items: 10 self-report items.
• Recall Timeframe: “Over the last week” (past 7 days).
• Response Format: 5-point Likert scale rated as:
  • 0 = ‘Not at all’
  • 1 = ‘Only occasionally’
  • 2 = ‘Sometimes’
  • 3 = ‘Often’
  • 4 = ‘Most or all of the time’
• Scoring and Transformation Rules:
  • Standard Items: Items 1, 4, 5, 6, 7, 8, 9, and 10 are positively scored from 0 to 4 (where 0 = ‘Not at all’ and 4 = ‘Most or all of the time’).
  • Reverse Scored Items: Items 2 and 3 represent positive functioning and are reverse-scored:
    • ‘Not at all’ = 4
    • ‘Only occasionally’ = 3
    • ‘Sometimes’ = 2
    • ‘Often’ = 1
    • ‘Most or all of the time’ = 0
  • Total Score: Calculated by summing all 10 item scores (range: 0 to 40).
  • Mean Clinical Score: Calculated by dividing the total score by 10 (range: 0.0 to 4.0).
  • Missing Data Rules: If one item is missing, substitute the mean of the remaining nine completed items. If more than one item is missing, the total score should not be computed.
• Clinical Severity Bands:
  • 0 to 10: Non-clinical range (general population normative levels)
  • 11 to 14: Mild psychological distress (clinical threshold / caseness begins at 11)
  • 15 to 19: Moderate psychological distress
  • 20 to 24: Moderate-to-severe psychological distress
  • 25 to 40: Severe psychological distress
• Critical Risk Item: Item 6 (“I made plans to end my life”) is an active suicidality marker. Any non-zero score (scores 1, 2, 3, or 4) warrants immediate, independent clinical risk assessment regardless of the aggregate total score.

11. Permissions & Fee and Test Year

The CORE-10 was developed and published by the CORE System Group, with initial psychometric development and normative manual release in 2007 and definitive peer-reviewed validation published by Barkham et al. in 2013. In accordance with the CORE System Group’s philosophical commitment to fostering accessible, standardized mental health measurement, the CORE-10 is an open-access instrument.

The copyright of the instrument is held by CORE System Trust (CST). The measure is freely available for clinical, educational, and non-commercial research purposes without royalty fees or licensing charges, provided that the text, item wording, and response format are reproduced exactly as published without unauthorized alterations, truncation, or item reordering. Commercial software developers seeking to integrate the CORE-10 into proprietary electronic health record (EHR) platforms or charging software suites must obtain formal licensing permission from the CORE System Trust. Official instrument copies, authorized language translations, and user scoring manuals can be downloaded directly from the official CORE System Trust website (www.coresystemtrust.org.uk).

12. References

• Barkham, M., Bewick, B., Mullin, T., Gilbody, S., Connell, J., Cahill, J., Mellor-Clark, J., Richards, D., Unsworth, G., & Evans, C. (2013). The CORE-10: A short measure of psychological distress for routine use in the psychological therapies. Counselling and Psychotherapy Research, 13(1), 3–13. https://doi.org/10.1080/14733145.2012.729069
• Barkham, M., Margison, F., Leach, C., Lucock, M., Mellor-Clark, J., Evans, C., Benson, L., Connell, J., Audin, K., & McGrath, G. (2001). Service profiling and clinical benchmark utility of the Clinical Outcomes in Routine Evaluation-Outcome Measure (CORE-OM) in psychological therapies. British Journal of Psychiatry, 179(5), 436–444. https://doi.org/10.1192/bjp.179.5.436
• Caspi, A., Houts, R. M., Belsky, D. W., Goldman-Mellor, S. J., Harrington, H., Israel, S., Meier, M. H., Ramrakha, S., Shalev, I., Poulton, R., & Moffitt, T. E. (2014). The p factor: One general psychopathology factor in the structure of psychiatric disorders? Clinical Psychological Science, 2(2), 119–137. https://doi.org/10.1177/2167702613497473
• Connell, J., Barkham, M., Stiles, W. B., Twigg, E., Hardy, G. E., & Evans, C. (2007). Changes in CORE-OM scores over time: A study of UK counseling services. Psychotherapy Research, 17(2), 168–179. https://doi.org/10.1080/10503300600650974
• CORE System Group. (2007). CORE-10 User Manual. CORE System Trust. https://www.coresystemtrust.org.uk/instruments/core-10-information/
• Evans, C., Connell, J., Barkham, M., Margison, F., McGrath, G., Mellor-Clark, J., & Audin, K. (2002). Towards a standardised brief outcome measure: Psychometric properties and utility of the CORE-OM. British Journal of Psychiatry, 180(1), 51–60. https://doi.org/10.1192/bjp.180.1.51
• Howard, K. I., Lueger, R. J., Maling, M. S., & Martinovich, Z. (1993). A phase model of psychotherapy outcome: Empirical support and clinical implications. Psychotherapy Research, 3(4), 211–227. https://doi.org/10.1080/10503309312331333801
• Jacobson, N. S., & Truax, P. (1991). Clinical significance: A statistical approach to defining meaningful change in psychotherapy research. Journal of Consulting and Clinical Psychology, 59(1), 12–19. https://doi.org/10.1037/0022-006X.59.1.12
• Twigg, E., Barkham, M., Bewick, B. M., Mulhern, B., Connell, J., & Cooper, M. (2009). The Young Person’s CORE: Development of a brief outcome measure for young people. Counselling and Psychotherapy Research, 9(4), 236–244. https://doi.org/10.1080/14733140902979722

13. Items of the Scale (Questionnaire)